Protalix director gets 17K options, 8.5K RSUs
Director Eliot Forster received new stock options and RSU awards in PLX as part of his equity compensation.
Rhea-AI Filing Summary
Protalix BioTherapeutics, Inc. (PLX) reported that director Eliot Forster received equity awards on September 3, 2026. He was granted stock options for 17,000 shares of common stock at an exercise price of $2.59 per share, expiring September 3, 2036, vesting in 12 equal quarterly installments from the grant date. He was also granted 8,500 restricted stock units, each representing one share of common stock, which also vest in 12 equal quarterly installments from the grant date. Separately, he already holds options for 85,715 shares at $1.75 expiring September 14, 2033 and 15,000 shares at $1.64 expiring September 3, 2035.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 25,500 shares
Grant/Award
2 txns
Insider
Forster Eliot
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) F1, F2 | 17,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units F3, F4 | 8,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 17,000 contracts (Direct);
Restricted Stock Units — 8,500 contracts (Direct)
Footnotes (4)
- F1. The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
- F2. Does not include (i) options to purchase 85,715 shares of common stock at an exercise price equal to $1.75 per share that expire on September 14, 2033, and (ii) options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
- F3. Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
- F4. The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Key Figures
Stock options granted: 17,000 shares
Option exercise price: $2.59 per share
Option expiration: September 3, 2036
+3 more
6 metrics
Stock options granted
17,000 shares
Options for common stock granted to Eliot Forster on September 3, 2026
Option exercise price
$2.59 per share
Exercise price of 17,000 stock options granted September 3, 2026
Option expiration
September 3, 2036
Expiration date of the 17,000 stock options granted to Eliot Forster
Restricted stock units granted
8,500 units
RSUs granted to Eliot Forster on September 3, 2026, each for one share
Prior options at $1.75
85,715 shares
Existing options at $1.75 per share expiring September 14, 2033, not included in new totals
Prior options at $1.64
15,000 shares
Existing options at $1.64 per share expiring September 3, 2035, not included in new totals
Key Terms
restricted stock unit (RSU), exercise price, vest in 12 equal quarterly installments, expire
4 terms
restricted stock unit (RSU) financial
"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
exercise price financial
"options to purchase 85,715 shares of common stock at an exercise price equal to $1.75 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in 12 equal quarterly installments financial
"The shares of common stock underlying the stock options vest in 12 equal quarterly installments"
expire financial
"options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035"
FAQ
What equity awards did director Eliot Forster receive from PLX on September 3, 2026?
He received stock options for 17,000 shares of Protalix common stock at an exercise price of $2.59 per share and 8,500 restricted stock units, each representing one share of common stock, all granted on September 3, 2026.
How do the new stock options granted to Eliot Forster by PLX vest?
The shares of common stock underlying the new stock options vest in 12 equal quarterly installments commencing on the grant date, September 3, 2026, spreading vesting evenly over three years.
How do the restricted stock units granted to Eliot Forster by PLX vest?
The shares of common stock underlying the 8,500 RSUs vest in 12 equal quarterly installments commencing on the grant date. Each restricted stock unit represents the right to receive, following vesting, one share of the issuer's common stock.
What is the exercise price and expiration date of Eliot Forster’s new PLX stock options?
The new stock options have an exercise price of $2.59 per share and expire on September 3, 2036, providing a long-dated right to purchase Protalix common stock if vested.
What other Protalix stock options did Eliot Forster hold before these new grants?
He already held options to purchase 85,715 shares at $1.75 per share expiring September 14, 2033 and options to purchase 15,000 shares at $1.64 per share expiring September 3, 2035, which are not included in the new award totals.
Were Eliot Forster’s September 3, 2026 PLX equity awards made under a Rule 10b5-1 trading plan?
No. The filing indicates that the Rule 10b5-1 checkbox is not selected, so the reported September 3, 2026 equity grants are not affirmed as being made under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
